The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Crystal Structure of Human Cyclophilin A Bound to the Amino-Terminal Domain of HIV-1 Capsid
Open accessAbstract
The HIV-1 capsid protein forms the conical core structure at the center of the mature virion. Capsid also binds the human peptidyl prolyl isomerase, cyclophilin A, thereby packaging the enzyme into the virion. Cyclophilin A subsequently performs an essential function in HIV-1 replication, possibly helping to disassemble the capsid core upon infection. We report the 2.36 A crystal structure of the N-terminal domain of HIV-1 capsid (residues 1-151) in complex with human cyclophilin A. A single exposed capsid loop (residues 85-93) binds in the enzyme's active site, and Pro-90 adopts an unprecedented trans conformation. The structure suggests how cyclophilin A can act as a sequence-specific binding protein and a nonspecific prolyl isomerase. In the crystal lattice, capsid molecules assemble into continuous planar strips. Side by side association of these strips may allow capsid to form the surface of the viral core. Cyclophilin A could then function by weakening the association between capsid strips, thereby promoting disassembly of the viral core.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A beta-hairpin is formed by the N-terminal residues in mature-like CA, stabilized by a salt bridge between the N-terminal proline and a conserved aspartate in helix 3”
From Retrovirus maturation-an extraordinary structural transformation (2016) · cites this paper as [72]
Citations
Cites
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581 · cited 1×
“Cyclophilin A is (bonds) 5 0.005 Å; RMSD (angles) 5 1.38; there are no w,c angles required for the replication of group M human immunodeficiency in the forbidden range (Laskowski et al., 1993).”
BackgroundInfluentialMOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,011 · cited 1×
“(B) and (C) were prepared with MOLSCRIPT (Kraulis, 1991) and RASTER 3D (Bacon and Anderson, 1988). about CA151 residues 86 and 98, so that CypA and CA151 CypA active site groove.”
MethodJones, T. A., Zou, J.-Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,616 · cited 1×
“Mode of action of SDZ NIM spersed with model building using O (Jones et al., 1991).”
MethodLIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · Protein Engineering Design and Selection · doi:10.1093/protein/8.2.127 · Cited by 5,731 · cited 1×
“Schematic representation of the CA151 and CypA interface (Wallace et al., 1995).”
BackgroundAMoRe: an automated package for molecular replacement
Navaza, J. (1994) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767393007597 · Cited by 4,941
X-PLOR Version 3.1: A System for X-ray Crystallography and NMR
Brünger, A. T. (1992) · Medical Entomology and Zoology · Cited by 3,424
The mechanism of action of cyclosporin A and FK506
Schreiber, S. L., & Crabtree, G. R. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90111-j · Cited by 2,127 · cited 1×
“Schreiber and Crabtree have proposed that CypA does not normally function as an enzyme in vivo However, it is possible that kcat/Km is similar to that of other substrates because kcat and Km have been(Schreiber and Crabtree, 1992).”
BackgroundImproved Fourier coefficients for maps using phases from partial structures with errors
Read, R. J. (1986) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767386099622 · Cited by 1,870
PROMOTIF—A program to identify and analyze structural motifs in proteins
Hutchinson, E. G., & Thornton, J. M. (1996) · Protein Science · doi:10.1002/pro.5560050204 · Cited by 1,043 · cited 1×
“The last six residues of both CA151 molecules are (A) Secondary structure of CA151 (Hutchinson and Thornton, 1996).”
BackgroundHuman Retroviruses and Aids - 1999
KUIKEN, C. L., & Foley, B. T. (1999) · doi:10.2172/1186019 · Cited by 952
Research works printed but not linked: 3
- Cowtan, 1994, ′dm′, Joint CCP, 34
- Gelderblom, H.R., Bauer, P.G.Özel, M., Höglund, S., Niedrig, M., Renz, H., Morath, B., Lundquist, P., NilssonÅ., Mattow, J., et al. (1992). Morphogenesis and morphology of human immunodeficiency virus. In Membrane Interactions of HIV, R.C. Aloia, and C.C. Curtain, eds. (New York: Wiley-Liss, Inc.), pp. 33–54.
- Otwinowski, Z. (1993). Oscillation data reduction program. In Data Collection and Processing, L. Sawyer, N. Isaacs, and S. Bailey, eds. (Warrington, England: SERC Daresbury Laboratory), pp. 56–62.
Cited by
Sorted by citations
Items 201–300 of 710
Identification of Capsid Mutations That Alter the Rate of HIV-1 Uncoating in Infected Cells
Hulme, A. E., Kelley, Z. L., Okocha, E. A., & Hope, T. J. (2014) · Journal of Virology · doi:10.1128/jvi.03043-14 · Cited by 67
“mutations disrupt cyclophilin A (CypA) binding (30).”
BackgroundAnti‐retroviral activity of TRIM5α
Nakayama, E. E., & Shioda, T. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.637 · Cited by 71
FEZ1 Is Recruited to a Conserved Cofactor Site on Capsid to Promote HIV-1 Trafficking
Huang, P.-T., Summers, B. J., Xu, C., Perilla, J. R., Malikov, V., Naghavi, M. H., & Xiong, Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.079 · Cited by 69
Grättinger, M., Hohenberg, H., Thomas, D. R., Wilk, T., Müller, B., & Kräusslich, H. (1999) · Virology · doi:10.1006/viro.1999.9668 · Cited by 70
Uncoating of Human Immunodeficiency Virus Type 1 Requires Prolyl Isomerase Pin1
Misumi, S., INOUE, M., Dochi, T., Kishimoto, N., Hasegawa, N., Takamune, N., & Shoji, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114256 · Cited by 70
Bukovsky, A. A., Weimann, A., Accola, M. A., & Göttlinger, H. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10943 · Cited by 70
Implication of TRIMalpha and TRIMCyp in interferon-induced anti-retroviral restriction activities
Carthagéna, L., Parise, M. C., Ringeard, M., Chelbi‐Alix, M. K., Hazan, U., & Nisole, S. (2008) · Retrovirology · doi:10.1186/1742-4690-5-59 · Cited by 70
“This cellular protein has been shown to bind the HIV-1 capsid protein (CA) through a direct interaction between the active site of CypA and an exposed loop within the CA protein, known as the CypA binding loop [16,17].”
BackgroundStructural and Functional Analysis of the C-Terminal Domain of Nup358/RanBP2
Lin, D. H., Zimmermann, S., Stuwe, T., Stuwe, E., & Hoelz, A. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.01.021 · Cited by 70
The molecular basis of HIV capsid assembly—five years of progress
Adamson, C. S., & Jones, I. M. (2004) · Reviews in Medical Virology · doi:10.1002/rmv.418 · Cited by 69
“The cleavage causes the N-terminal CA residues to fold back to form a -hairpin involving a salt bridge between the proline at the processed N-terminus and a buried aspartate residue [25,26].”
BackgroundNi, T., Gérard, S. F., Zhao, G., Dent, K. C., Ning, J., Zhou, J., Shi, J., Anderson-Daniels, J., Li, W., Jang, S., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0467-8 · Cited by 66
Engineering cyclophilin into a proline-specific endopeptidase
Quéméneur, É., Moutiez, M., Charbonnier, J., & Ménez, A. (1998) · Nature · doi:10.1038/34687 · Cited by 68
“and a trans conformation in a Gly-Pro bond of a HIV1-gag hCyPA comple”
Backgrounddel Álamo, M., Neira, J. L., & Mateu, M. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304466200 · Cited by 67
Agarwal, P. K. (2004) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20135 · Cited by 66
“mutated CA) have provided insights into the interactions within the complex.(30,33) A better understanding of the”
BackgroundMethodCyclophilin A: A Key Factor in Virus Replication and Potential Target for Anti-viral Therapy
Dawar, F. U., Tu, J., Khattak, M. N. K., Mei, J., & Lin, L. (2016) · Current Issues in Molecular Biology · doi:10.21775/cimb.021.001 · Cited by 64
“The Gly89 and Pro90 amino acids are the binding sites for catalytic domain of CypA (Gamble et al., 1996), which are easily accessible to CypA in the cytosol of the newly infected cell.”
BackgroundMassiah, M. A., Worthylake, D. K., Christensen, A. M., Sundquist, W. I., Hill, C. P., & Summers, M. F. (1996) · Protein Science · doi:10.1002/pro.5560051202 · Cited by 65
“With our more recent structure determination of the amino-terminal core domain of the HIV-1 capsid protein in solution-(Gitti et al., 1996) and solid-states (Gamble et al., 1996, Momany et al., 1996). structural information is now available for each of the major Gag gene products (Fig.”
BackgroundSelf-citationMelamed, D., Mark‐Danieli, M., Kenan-Eichler, M., Kraus, O., Castiel, A., Laham-Karam, N., Pupko, T., Glaser, F., Ben‐Tal, N., & Bacharach, E. (2004) · Journal of Virology · doi:10.1128/jvi.78.18.9675-9688.2004 · Cited by 63
“Interaction between the CA domain and the cellular protein cyclophilin A results in incorporation of the cellular factor into the assembled virion, and this interaction is important for HIV-1 infectivity (22, 26, 52, 84).”
BackgroundGanser, B. K., Cheng, A., Sundquist, W. I., & Yeager, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg276 · Cited by 65
“High-resolution structures have now been determined for a number of CA proteins, which demonstrate that the retroviral CA tertiary structure is highly conserved ( Gamble et al., 1996, 1997; Gitti et al., 1996; Momany et al., 1996; Berthet-Colominas et al., 1999; Jin et al., 1999; Khorasanizadeh et al., 1999; Campos-Ol…”
BackgroundSelf-citationStrategies to overcome HIV drug resistance-current and future perspectives
Temereanca, A., & Ruță, S. M. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1133407 · Cited by 71
Mateu, M. G. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00091-8 · Cited by 64
Goldstone, D. C., Yap, M. W., Robertson, L. E., Haire, L. F., Taylor, W. R., Katzourakis, A., Stoye, J. P., & Taylor, I. A. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.08.006 · Cited by 64
“HIV-1 particles contain substantial quantities of CypA (Braaten et al., 1996), and CypA binds to a region on the amino-terminal domain of the capsid protein (CA-NtD), referred to as the CypA-binding loop (Gamble et al., 1996).”
BackgroundResultInfluentialDebing, Y., Neyts, J. H., & Delang, L. (2015) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000212 · Cited by 64
“For HIV, it was reported that CypA binds to the capsid protein p24 [64].”
BackgroundSaito, A., Henning, M. S., Serrao, E., Dubose, B. N., Teng, S., Huang, J., Li, X., Saito, N., Roy, S. P., Siddiqui, M. A., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00019-16 · Cited by 61
“Amino acid sequences of the CypA-binding loop vary across different primate immunodeficiency viruses (41–43) as well as between various strains of HIV-1 (44).”
BackgroundInfluentialNermut, M. V., HOCKLEY, D. J., Bron, P., Thomas, D., Zhang, W., & Jones, I. M. (1998) · Journal of Structural Biology · doi:10.1006/jsbi.1998.4024 · Cited by 64
Structural analysis of the N-terminal domain of the human T-cell leukemia virus capsid protein
Cornilescu, C. C., Bouamr, F., Yao, X., Carter, C., & Tjandra, N. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4395 · Cited by 64
Retroviral Capsid Determinants of Fv1 NB and NR Tropism
Stevens, A., Bock, M., Ellis, S., Tissier, P. L., Bishop, K. N., Yap, M. W., Taylor, W., & Stoye, J. P. (2004) · Journal of Virology · doi:10.1128/jvi.78.18.9592-9598.2004 · Cited by 64
“includes the cyclophilin binding domain (15), which has al-”
BackgroundPeptide Bond cis/trans Isomerases: A Biocatalysis Perspective of Conformational Dynamics in Proteins
Schiene‐Fischer, C., Aumüller, T., & Fischer, G. S. (2011) · Topics in current chemistry · doi:10.1007/128_2011_151 · Cited by 63
Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain
Zhang, H., Curreli, F., Zhang, X., Bhattacharya, S., Waheed, A. A., Cooper, A., Cowburn, D., Freed, E. O., & Debnath, A. K. (2011) · Retrovirology · doi:10.1186/1742-4690-8-28 · Cited by 63
A Machine Learning Approach for Hot-Spot Detection at Protein-Protein Interfaces
Melo, R., Fieldhouse, R. J., Melo, A., Correia, J. D. G., Cordeiro, M. N. D. S., Gumus, Z. H., da Costa, J. P., Bonvin, A. M. J. J., & Moreira, I. S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081215 · Cited by 60
TRIM5α self-assembly and compartmentalization of the HIV-1 viral capsid
Yu, A., Skorupka, K. A., Pak, A. J., Ganser‐Pornillos, B. K., Pornillos, O., & Voth, G. A. (2020) · Nature Communications · doi:10.1038/s41467-020-15106-1 · Cited by 72
Mechanistic Insight into the Role of Transition-State Stabilization in Cyclophilin A
Hamelberg, D., & McCammon, J. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja806146g · Cited by 62
Early Stages of the HIV-1 Capsid Protein Lattice Formation
Grime, J. M. A., & Voth, G. A. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.09.007 · Cited by 63
Implications for Viral Capsid Assembly from Crystal Structures of HIV-1 Gag1-278 and CAN133-278,
Kelly, B. N., Howard, B. R., Wang, H., Robinson, H. H., Sundquist, W. I., & Hill, C. P. (2006) · Biochemistry · doi:10.1021/bi060927x · Cited by 61
Self-citationJoshi, A., Nagashima, K., & Freed, E. O. (2006) · Journal of Virology · doi:10.1128/jvi.00355-06 · Cited by 60
“, the N-terminal domain (NTD), which plays a crucial role in virion maturation (see below), and the C-terminal domain (CTD), which bears residues necessary for Gag-Gag oligomerization (17, 18).”
BackgroundZhong, Z., Ning, J., Boggs, E. A., Jang, S., Wallace, C. T., Telmer, C. A., Bruchez, M. P., Ahn, J., Engelman, A., Zhang, P., et al. (2021) · mBio · doi:10.1128/mbio.03142-20 · Cited by 57
“Two examples are cyclophilin A (CypA) (Gamble et al., 1996; Luban et al., 1993), which is relatively abundant in cells (Koletsky et al.”
BackgroundCyclophilins as Modulators of Viral Replication
Frausto, S. D., Lee, E. M., & Tang, H.-L. (2013) · Viruses · doi:10.3390/v5071684 · Cited by 63
“Subsequently it was reported that CyPA, but not CyPB, is specifically incorporated into HIV-1 virions [53,54] via a specific interaction between residues G89 and P90 of the HIV-1 capsid (CA) and the active site of CyPA [55,56].”
BackgroundRole of Human Immunodeficiency Virus Type 1 Integrase in Uncoating of the Viral Core
Briones, M. S., Dobard, C., & Chow, S. A. (2010) · Journal of Virology · doi:10.1128/jvi.02382-09 · Cited by 59
“CypA is a ubiquitously expressed cytoplasmic peptidyl-prolyl isomerase (37, 48, 57) that recognizes an exposed loop on CA and catalyzes the isomerization of the peptide bond linking G89 and P90 in CA (6, 24).”
BackgroundIttig, D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh187 · Cited by 59
Yang, R., Shi, J., Byeon, I. L., Ahn, J., Sheehan, J. H., Meiler, J., Gronenborn, A. M., & Aiken, C. (2012) · Retrovirology · doi:10.1186/1742-4690-9-30 · Cited by 56
“Interactions between the Nterminal domains (NTDs) form hexamers through an intersubunit NTD-NTD interface, while the Cterminal domains (CTDs) form dimers that connect adjacent hexamers through a C TD-CTD interface [1-5].”
BackgroundSecond-Site Suppressors of Rous Sarcoma Virus CA Mutations: Evidence for Interdomain Interactions
Bowzard, J. B., Wills, J. W., & Craven, R. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6850-6856.2001 · Cited by 58
“The folding of the two protein domains is similar to those in dimers of HIV-1 CA (10, 11, 15) and equine infectious anemia virus (EIAV) CA (18) and monomers of human T-cell leukemia virus CA (20).”
GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple Grounds
Singh, K. D., Gallazzi, F., Hill, K. J., Burke, D. H., Lange, M. J., Quinn, T. P., Neogi, U., & Sönnerborg, A. B. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01227 · Cited by 60
HIV capsid and integration targeting
Engelman, A. N. (2021) · Viruses · doi:10.3390/v13010125 · Cited by 57
“The host factor cyclophilin A (CypA) engages CA via the CypA-binding loop [30].”
BackgroundInfluentialOrganization of HIV-1 Capsid Proteins on a Lipid Monolayer
Barklis, E., McDermott, J., Wilkens, S., Fuller, S., & Thompson, D. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7177 · Cited by 57
Two structural switches in HIV-1 capsid regulate capsid curvature and host factor binding
Stacey, J. C. V., Tan, A., Lu, J. M., James, L. C., Dick, R. A., & Briggs, J. A. G. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220557120 · Cited by 58
“The CypA-binding loop constitutes a flexible span of residues between helices 4 and 5, and binds cyclophilin A (CypA) (21) and nuclear pore component Nup358, which contains a CypA domain (22, 23).”
Roles of HIV-1 capsid in viral replication and immune evasion
Sage, V. L., Mouland, A. J., & Valiente‐Echeverría, F. (2014) · Virus Research · doi:10.1016/j.virusres.2014.07.010 · Cited by 59
Assembly of Human Immunodeficiency Virus Precursor Gag Proteins
Huseby, D. L., Barklis, R. L., Alfadhli, A., & Barklis, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412325200 · Cited by 56
Catalysis of protein folding by parvulin 1 1Edited by P. E. Wright
Scholz, C., Rahfeld, J., Fischer, G. S., & Schmid, F. X. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1301 · Cited by 56
Highland, C. M., Tan, A., Ricana, C. L., Briggs, J. A. G., & Dick, R. A. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220545120 · Cited by 56
Du, S., Betts, L., Yang, R., Shi, H., Concel, J., Ahn, J., Aiken, C., Zhang, P., & Yeh, J. I. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.11.027 · Cited by 55
Human MxB Inhibits the Replication of Hepatitis C Virus
Yi, D., An, N. A., Liu, Z., Xu, F., Raniga, K., Li, Q., Zhou, R., Wang, J., Zhang, Y., Zhou, J., et al. (2018) · Journal of Virology · doi:10.1128/jvi.01285-18 · Cited by 55
Wiegers, K. J., Rütter, G., Schubert, U., Grättinger, M., & Kräusslich, H. (1999) · Virology · doi:10.1006/viro.1999.9669 · Cited by 54
Genetic Determinants of Rous Sarcoma Virus Particle Size
Krishna, N. K., Campbell, S., Vogt, V., & Wills, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.564-577.1998 · Cited by 57
“This interpretation is compatible with models of the HIV capsid structure (13, 14, 17).”
ResultOhkura, S., Goldstone, D. C., Yap, M. W., Holden-Dye, K., Taylor, I. A., & Stoye, J. P. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002011 · Cited by 53
“Taken together, these variable determinants of restriction imply that TRIM5α recognizes its targets in a manner significantly different from many protein-protein interactions that involve a small number of highly conserved residues, exemplified by the interaction betweens HIV-1 CA and the cellular protein cyclophilin A”
A dynamical view of protein-protein complexes: Studies by molecular dynamics simulations
Martin, J., & Frezza, E. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.970109 · Cited by 54
“, 2001) and cyclophilin/HIV capsid complex 1AK4 (Gamble et al., 1996)).”
Site-Specific Structural Variations Accompanying Tubular Assembly of the HIV-1 Capsid Protein
Bayro, M. J., Chen, B., Yau, W., & Tycko, R. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.12.021 · Cited by 54
Characterization of the In Vitro HIV-1 Capsid Assembly Pathway
Barklis, E., Alfadhli, A., McQuaw, C. M., Yalamuri, S. M., Still, A., Barklis, R. L., Kukull, B., & López, C. S. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.058 · Cited by 54
Sanz-Ramos, M., & Stoye, J. P. (2013) · Journal of General Virology · doi:10.1099/vir.0.058180-0 · Cited by 54
Simões, I. C. M., Costa, I. P. D., Coimbra, J. T. S., Ramos, M. J., & Fernandes, P. A. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00378 · Cited by 52
Goulder, P., Jeena, P. M., Tudor‐Williams, G., & Burchett, S. K. (2001) · British Medical Bulletin · doi:10.1093/bmb/58.1.89 · Cited by 52
Guo, X., Roldán, A., Hu, J., Wainberg, M. A., & Liang, C. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1803-1812.2005 · Cited by 53
“CA consists of two independently folded regions, termed the N-terminal domain (NTD) and the C-terminal domain (CTD), that are connected by a flexible linker (4, 13 , 14, 35).”
BackgroundZhuang, S., & Torbett, B. E. (2021) · Viruses · doi:10.3390/v13030417 · Cited by 53
“Cyclophilin A (CypA) is a peptidyl-prolyl cis-trans isomerase (PPIase), which binds to the flexible CypA-binding loop exposed on the top of CA N-terminal domain that protrudes from the capsid outer surface [43] (Figure 2).”
BackgroundJiang, J., Ablan, S. D., Derebail, S. S., Hercík, K., Soheilian, F., Thomas, J. A., Tang, S., HEWLETT, I. K., Nagashima, K., Gorelick, R. J., et al. (2011) · Virology · doi:10.1016/j.virol.2011.09.012 · Cited by 57
“The N-terminal domain (NTD) of CA forms the hexameric lattice and each hexamer is linked to six others by interactions with C-terminal CA dimers (Briggs et al., 2006; Ganser et al., 1999; Ganser-Pornillos et al., 2004, 2007; Huseby et al., 2005; Lanman and Prevelige, 2005; Lanman et al., 2003; Li et al., 2000; Pornill…”
InfluentialChen, B., & Tycko, R. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.05.025 · Cited by 51
“The 146-residue NTD includes a b-hairpin and seven a-helices (37,38).”
BackgroundChen, B., & Tycko, R. (2010) · Protein Science · doi:10.1002/pro.348 · Cited by 54
HIV Capsid Assembly, Mechanism, and Structure
Chen, B. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00159 · Cited by 57
Quinn, C. M., Wang, M., Fritz, M. P., Runge, B., Ahn, J., Xu, C., Perilla, J. R., Gronenborn, A. M., & Polenova, T. E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800796115 · Cited by 53
“As a result, the NTD harbors the interaction epitopes for restriction factors, such as cyclophilin A (CypA) and tripartite motif isoform 5α (TRIM5α) (13, 14).”
BackgroundGatanaga, H., Das, D., Suzuki, Y., Yeh, D. D., Hussain, K. A., Ghosh, A. K., & Mitsuya, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505920200 · Cited by 52
Investigation of N-Terminal Domain Charged Residues on the Assembly and Stability of HIV-1 CA
Douglas, C. C., Thomas, D. R., Lanman, J. K., & Prevelige, P. E. (2004) · Biochemistry · doi:10.1021/bi049359g · Cited by 51
“High-resolution structures of CA obtained by X-ray crystallography and NMR demonstrate that it is composed of structurally distinct N- and C-terminal domains ( 24-28 ).”
Tang, S., Murakami, T., Cheng, N., Steven, A. C., Freed, E. O., & Levin, J. G. (2003) · Journal of Virology · doi:10.1128/jvi.77.23.12592-12602.2003 · Cited by 52
“Residues 85 to 93 in the exposed proline-rich loop (27, 73) constitute the binding site for CypA (49), a host peptidyl-prolyl cis-trans isomerase that is incorporated into virions (21, 54, 61).”
BackgroundAlcaraz, L. A., del Álamo, M., Barrera, F. N., Mateu, M. G., & Neira, J. L. (2007) · Biophysical Journal · doi:10.1529/biophysj.106.101089 · Cited by 51
Reidt, U., Wahl, M. C., Fasshauer, D., Horowitz, D. S., Lührmann, R., & Ficner, R. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00684-3 · Cited by 51
Mortuza, G. B., Dodding, M. P., Goldstone, D. C., Haire, L. F., Stoye, J. P., & Taylor, I. A. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.12.043 · Cited by 56
Virus–host interactomes — antiviral drug discovery
Ma‐Lauer, Y., Lei, J., Hilgenfeld, R., & von Brunn, A. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.09.003 · Cited by 49
“(CA) is available [49] .”
Conformational Adaptation of Asian Macaque TRIMCyp Directs Lineage Specific Antiviral Activity
Ylinen, L. M. J., Price, A. J., Rasaiyaah, J., Hué, S., Rose, N. J., Marzetta, F., James, L. C., & Towers, G. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001062 · Cited by 49
“). As stated above, there are two amino acid differences between the Cyp domain of Mafa TRIMCyp and the genomic CypA sequence, R69H and E143K. Superposition of the Mafa:HIV-1 complex with the previously solved wild-type CypA:HIV-1 structure (1AK4)”
BackgroundSUN2 Overexpression Deforms Nuclear Shape and Inhibits HIV
Donahue, D. A., Amraoui, S., Nunzio, F. D., Kieffer, C., Porrot, F., Opp, S., Diaz‐Griffero, F., Casartelli, N., & Schwartz, O. (2016) · Journal of Virology · doi:10.1128/jvi.03202-15 · Cited by 51
The ability of multimerized cyclophilin A to restrict retrovirus infection
Javanbakht, H., Diaz‐Griffero, F., Yuan, W., Yeung, D. F., Li, X., Song, B., & Sodroski, J. (2007) · Virology · doi:10.1016/j.virol.2007.04.034 · Cited by 50
“…with both the unprocessed HIV-1 Gag polyprotein and the processed capsid protein with low affinity (Franke et al., 1994; Thali et al., 1994; Gamble et al., 1996; Yoo et al., 1997), we show here that the ability of multimeric cyclophilin A to restrict retroviruses correlates with an…”
BackgroundIntracellular Trafficking of HIV-1 Cores: Journey to the Center of the Cell
Dvorin, J. D., & Malim, M. H. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-19012-4_5 · Cited by 49
Scholz, I., Arvidson, B., Huseby, D. L., & Barklis, E. (2005) · Journal of Virology · doi:10.1128/jvi.79.3.1470-1479.2005 · Cited by 49
“Some of these defects may be attributable to altered interactions with cellular factors, such as cyclophilin A (CypA) (1, 2, 7, 9, 41), and host susceptibility factors, such as Ref1, Trim5 , and Lv1 (6, 12, 16, 17, 24, 32, 37).”
BackgroundTroyano-Hernáez, P., Reinosa, R., & Holguín, Á. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.854974 · Cited by 48
Kane, J. R., Stanley, D. J., Hultquist, J. F., Johnson, J. R., Mietrach, N., Binning, J. M., Jönsson, S., Barelier, S., Newton, B. W., Johnson, T. L., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.038 · Cited by 49
“The motif bears some resemblance to the CYPA binding site of HIV-1 Capsid, 89GPIAP93 (Gamble et al., 1996), a GPxxP motif.”
In Vitro Assembly of Retroviruses
Bush, D. L., & Vogt, V. M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085427 · Cited by 49
HIV-1 requires capsid remodelling at the nuclear pore for nuclear entry and integration
Guedán, A., Donaldson, C. D., Caroe, E. R., Cosnefroy, O., Taylor, I. A., & Bishop, K. N. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009484 · Cited by 47
Dorfman, T., Weimann, A., Borsetti, A., Walsh, C. T., & Göttlinger, H. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.7110-7113.1997 · Cited by 52
“Our results are consistent with the recently solved crystal structures of CyPA bound to the N-terminal domain of HIV-1 CA (15) and to a 25-mer fragment of HIV-1 CA (37).”
BackgroundResultHost factors involved in resistance to retroviral infection
Takeuchi, H., & Matano, T. (2008) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2008.00040.x · Cited by 48
Detailed characterization of a cyclophilin from the human malaria parasite Plasmodium falciparum
Berriman, M., & Fairlamb, A. H. (1998) · Biochemical Journal · doi:10.1042/bj3340437 · Cited by 48
An intracellular block to primate lentivirus replication
Stoye, J. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192449399 · Cited by 48
The role of immunophilins in viral infection
Hopkins, S., & Gallay, P. A. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.11.011 · Cited by 47
Goudreau, N., Lemke, C. T., Faucher, A., Grand‐Maître, C., Goulet, S., Lacoste, J., Rancourt, J., Malenfant, É., Mercier, J.-F., Titolo, S., et al. (2013) · ACS Chemical Biology · doi:10.1021/cb400075f · Cited by 46
Joshi, S., & Vogt, V. (2000) · Journal of Virology · doi:10.1128/jvi.74.21.10260-10268.2000 · Cited by 49
“The first detailed model proposed to explain the tubular and spherical polymerization modes in vitro (35) invoked the presence or absence of the b-hairpin at the N terminus of mature CA (10, 15).”
BackgroundGarzón, M. T., Lidón‐Moya, M. C., Barrera, F. N., Prieto, A., Gómez, J., Mateu, M. G., & Neira, J. L. (2004) · Protein Science · doi:10.1110/ps.03555304 · Cited by 47
“Highresolution structures of both CA domains have been obtained (Gamble et al. 1996, 1997; Gitti et al. 1996).”
BackgroundYang, R., & Aiken, C. (2007) · Journal of Virology · doi:10.1128/jvi.02634-06 · Cited by 44
“CypA is a cellular peptidylprolyl isomerase that binds to the HIV-1 CA NTD and is incorporated into virions through interaction with an exposed loop between helices 4 and 5 in HIV-1 and SIVcpz CA proteins (19, 27).”
BackgroundVSV-G pseudotyping rescues HIV-1 CA mutations that impair core assembly or stability
Brun, S., Solignat, M., Gay, B., Bernard, É., Chaloin, L., Fenard, D., Devaux, C. A., Chazal, N., & Briant, L. (2008) · Retrovirology · doi:10.1186/1742-4690-5-57 · Cited by 46
“According to structural studies, monomeric CA folds into two distinct globular domains: the N-terminal domain (NTD) (residues 1 to 145) and the C-terminal domain (CTD) (residues 151–231) are connected by a short flexible linker that folds in a 310 helix upon oligomerization of CA [16-19].”
BackgroundBulli, L., Apolonia, L., Kutzner, J., Pollpeter, D., Goujon, C., Herold, N., Schwarz, S.-M., Giernat, Y., Keppler, O. T., Malim, M. H., et al. (2016) · Journal of Virology · doi:10.1128/jvi.00458-16 · Cited by 46
“In addition to CypA (62, 63) and CPSF6 (56, 57), HIV-1 CA has been proposed to bind to the nuclear pore complex (NPC) protein NUP153 (64), as well as to the cyclophilin domain of NUP358 (51, 65), and binding-deficient CA mutants have been characterized.”
BackgroundRecognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA
Yoh, S. M., Mamede, J. I., Lau, D., Ahn, N., Sánchez-Aparicio, M. T., Temple, J. E., Tuckwell, A., Fuchs, N. V., Cianci, G. C., Riva, L., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.06.010 · Cited by 47
Ackerson, B. K., Rey, O., Canon, J. R., & Krogstad, P. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.303-308.1998 · Cited by 45
“P217 is one of only nine CA residues which make a series of favorable contacts with the CyPA active site (17).”
BackgroundProline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities
Gurung, D., Danielson, J. A., Tasnim, A., Zhang, J., Zou, Y., & Liu, J. (2023) · Biology · doi:10.3390/biology12071008 · Cited by 50
“The N-terminal domain of the HIV-1 capsid (residues 1-151) has been captured complexed with CypA by X-ray crystallography [45] (PDB: 1AK4).”
BackgroundMethodInfluentialBattivelli, E., Migraine, J., Lecossier, D., Yéni, P., Clavel, F., & Hance, A. J. (2011) · Journal of Virology · doi:10.1128/jvi.05201-11 · Cited by 44
Guo, H., Feng, W. A. N. G., Yu, K., Chen, J., Bai, D., Chen, K., Shen, X., & Jiang, H. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00189.x · Cited by 45
Cyclophilin A enables specific HIV-1 Tat palmitoylation and accumulation in uninfected cells
Chopard, C., Tong, P. B. V., Tóth, P., Schatz, M., Yezid, H., Debaisieux, S., Mettling, C., Gross, A., Pugnière, M., Tu, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04674-y · Cited by 48
Structural Folds of Viral Proteins
Chapman, M. S., & Liljas, L. (2003) · Advances in protein chemistry · doi:10.1016/s0065-3233(03)01004-0 · Cited by 44
Scholz, C., Mücke, M., Rapé, M., Pecht, A., Pahl, A. M., Bang, H., & Schmid, F. X. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1604 · Cited by 45
Metadata
- Authors
- Gamble, T. R., Vajdos, F. F., Yoo, S., Worthylake, D. K., Houseweart, M., Sundquist, W. I., & Hill, C. P.
- Affiliations
- University of Utah (US)
- Corresponding author
- Hill, Christopher P
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1996-12
- Volume
- 87
- Issue
- 7
- Pages
- 1285-1294
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2121753315
- Cited by
- 706
- References
- 59
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 7 · 2023: 18 · 2022: 20 · 2021: 26 · 2020: 16 · 2019: 12 · 2018: 23 · 2017: 21 · 2016: 29 · 2015: 22 · 2014: 25 · 2013: 32 · 2012: 24
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- cyclophilin A, HIV-1 capsid, peptidyl-prolyl isomerase, protein-protein complex, capsid disassembly, viral core, capsid assembly, HIV-1 replication
- MeSH terms
- Amino Acid Isomerases, Capsid, Carrier Proteins, Humans, Models, Molecular, Protein Binding, Virion, HIV-1, Gene Products, gag, Protein Structure, Tertiary, Crystallography, X-Ray, Peptidylprolyl Isomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review